KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Encompass Health (EHC) over the last 17 years, with Q3 2025 value amounting to $3.1 million.

  • Encompass Health's Change in Receivables rose 11099.29% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.9 million, marking a year-over-year increase of 22071.43%. This contributed to the annual value of -$3.0 million for FY2024, which is 11339.29% down from last year.
  • As of Q3 2025, Encompass Health's Change in Receivables stood at $3.1 million, which was up 11099.29% from -$9.0 million recorded in Q2 2025.
  • In the past 5 years, Encompass Health's Change in Receivables registered a high of $55.1 million during Q1 2021, and its lowest value of -$28.2 million during Q3 2024.
  • Its 5-year average for Change in Receivables is $5.0 million, with a median of -$6.0 million in 2022.
  • Its Change in Receivables has fluctuated over the past 5 years, first plummeted by 99473.68% in 2021, then surged by 23707.87% in 2023.
  • Quarter analysis of 5 years shows Encompass Health's Change in Receivables stood at $28.6 million in 2021, then surged by 37.41% to $39.3 million in 2022, then grew by 9.67% to $43.1 million in 2023, then crashed by 39.44% to $26.1 million in 2024, then plummeted by 88.12% to $3.1 million in 2025.
  • Its last three reported values are $3.1 million in Q3 2025, -$9.0 million for Q2 2025, and $24.7 million during Q1 2025.